Paeds SAQs · gastroenterology-hepatology-and-nutrition
Pancreatitis and pancreatic disorders — formative SAQs
Two formative SAQs on pancreatitis and pancreatic disorders in children: the eight-year-old on valproate who presents with acute pancreatitis needing the NASPGHAN criteria and early aggressive hydration, and the child with recurrent pancreatitis who needs the genetic workup and the distinction between acute recurrent and chronic disease.
On this page & tools
Target exams
SAQ 1 — The child on valproate with acute pancreatitis (20 marks, ~15 minutes)
An eight-year-old boy with epilepsy presents to the emergency department with a two-day history of severe, constant epigastric abdominal pain radiating to the back, nausea and vomiting. He has been on valproate for three years. On examination he is tachycardic with marked epigastric tenderness. His serum lipase is six times the upper limit of normal. An abdominal ultrasound shows an enlarged, oedematous pancreas with no gallstones. [9]
Questions
- Give the diagnosis and state the NASPGHAN criteria that confirm it. (4 marks) [1]
- Outline the early management in the first forty-eight hours, including fluid resuscitation, analgesia and nutrition. (6 marks) [2]
- Explain the role of valproate and the immediate action required regarding the drug. (3 marks) [9]
- State the position on prophylactic antibiotics and explain the reasoning. (3 marks) [2]
- Outline the follow-up plan and the investigations to prevent recurrence. (4 marks) [5]
Model answer (must-hit)
-
The diagnosis is acute pancreatitis, likely medication-induced from valproate. The NASPGHAN criteria require at least two of three: characteristic abdominal pain (present — severe epigastric pain radiating to the back), a serum lipase or amylase at or above three times the upper limit of normal (present — six times), and imaging consistent with pancreatitis (present — enlarged oedematous pancreas on ultrasound). All three are met here, confirming the diagnosis. [1]
-
Early aggressive hydration with isotonic crystalloid, normal saline or lactated Ringer solution, at one and a half to two times the maintenance rate for the first twenty-four to forty-eight hours, titrated to urine output and clinical response. Adequate analgesia with age-appropriate opioids, because acute pancreatitis is severely painful and adequate analgesia does not mask surgical pathology once the diagnosis is established. Early enteral feeding within forty-eight to seventy-two hours as the child improves, starting with clear fluids and advancing to a low-fat diet, because early feeding reduces complications and length of stay compared with prolonged fasting. [2]
-
Valproate is one of the commonest medication causes of paediatric pancreatitis, acting through a direct toxic or idiosyncratic mechanism. It can occur at any time during treatment. The immediate action is to stop valproate and to engage the neurology team to find an alternative antiseizure medication, because continuing the drug risks recurrence. [9]
-
Prophylactic antibiotics are not recommended in acute pancreatitis, including in severe disease with necrosis, unless there is documented or strongly suspected infected necrosis. Routine antibiotics do not prevent infection, select resistant organisms, and do not improve outcomes. Antibiotics are reserved for proven infected necrosis, cholangitis or another documented infection. [2]
-
The follow-up plan includes confirming full biochemical recovery with a normal lipase before discharge, a medication review to ensure the offending drug is permanently replaced, counselling of the family on the drug trigger, and surveillance for recurrence. If the child has further episodes, a genetic panel including PRSS1, SPINK1, CFTR and CTRC, a metabolic screen for triglycerides and calcium, and a magnetic resonance cholangiopancreatography for ductal anatomy are indicated. [5]
You have read the opening of this SAQ. The complete unit — every section and its primary-source references — is part of the Paediatrics Fellowship fellowship atlas.
References5Show ledgerHide ledger
- [1]Abu-El-Haija M; Kumar S; Szabo F; Jażdżewska M; Ranganathan S; Werlin SL Classification of Acute Pancreatitis in the Pediatric Population: Clinical Report From the NASPGHAN Pancreas Committee. J Pediatr Gastroenterol Nutr, 2017.PMID 28333771
- [2]Abu-El-Haija M; Kumar S; Quiros JA; Balzer B; Durie PR; Elinoff B Management of Acute Pancreatitis in the Pediatric Population: A Clinical Report From the NASPGHAN Pancreas Committee. J Pediatr Gastroenterol Nutr, 2018.PMID 29280782
- [4]Taylor CJ; Chen K; Horvath K; Hughes J; Rothbaum R; Shun-Shin M ESPGHAN and NASPGHAN Report on the Assessment of Exocrine Pancreatic Function and Pancreatitis in Children. J Pediatr Gastroenterol Nutr, 2015.PMID 25915425
- [5]Kumar S; Ooi CY; Werlin S; Abu-El-Haija M; Barth B; Bellin MD Risk Factors Associated With Pediatric Acute Recurrent and Chronic Pancreatitis: Lessons From INSPPIRE. JAMA Pediatr, 2016.PMID 27064572
- [9]Husain SZ; Morinville V; Pohl J; Rabinowitz S; Arsenescu R; Barth BA Toxic-metabolic Risk Factors in Pediatric Pancreatitis: Recommendations for Diagnosis, Management, and Future Research. J Pediatr Gastroenterol Nutr, 2016.PMID 26594832